Search for: "Bayer A G"
Results 61 - 80
of 114
Sorted by Relevance
|
Sort by Date
29 Jul 2021, 8:04 am
’” Bayer Pharma AG v. [read post]
28 Jun 2017, 8:01 am
When Congress enacted Section 12203, it incorporated by reference the preexisting Title VII enforcement provision codified in Section 2000e-5(g)(1), said the court, pointing out that when Congress enacted the ADA, the vast majority of the courts of appeals to address the issue had concluded that Section 2000e-5(g) authorized nominal damages awards. [read post]
19 Aug 2008, 10:55 am
"As an expert who blogs occasionally," says security expert Kevin G. [read post]
24 Oct 2011, 5:00 am
Bayer. [read post]
17 Jan 2022, 1:08 am
According to the EPO guidelines, for example, "[e]ven an implicit prompting or implicitly recognisable incentive is sufficient to show that the skilled person would have combined the elements from the prior art " (G-IV-5.3). [read post]
24 Jan 2013, 5:00 pm
(Univ. of Oxford, Research Paper, Working Paper No 23/2006), p. 7. [6] Id. [7] See G. [read post]
1 May 2007, 8:34 am
Cir. 2004) (271(f) "component" does not cover export of plans/instructions of patented item to be manufactured abroad); Bayer v. [read post]
5 Aug 2009, 7:59 am
Gérard Coquerel Contact details: 0800 652 2363 or +44 (0) 20 7368 9300 or email enquire@iqpc.co.uk Related posts:Biotech Patents: Strategies for an Evolving Legal Climate The American Conference Institute's 11th Advanced Forum on Biotech Patents:...Book Review Monday: International Patent Litigation As the importance of technology-based products and processes continues to...Kentucky BioAlliance Annual Meeting and Reception Please join the Kentucky… [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
28 May 2014, 10:48 pm
#aipla Bayer’s Jacqueline De Gagné presents excellent rundown of contrasts between US and Canada IP litigation at #aipla panel — Expert “hot tub” No, I couldn’t include the Twitter handles of any of these distinguished attorneys because, as far as I could tell, not one of them had one. [read post]
17 Feb 2010, 2:29 pm
Bayer Healthcare LLC, No. 1:10-cv-00001-SLR (D. [read post]
22 Jun 2009, 12:24 pm
Peter G. [read post]
27 Sep 2018, 12:12 pm
P&G intends to cross-appeal the NAD’s finding that P&G’s study constitutes competent and reliable evidence for superiority claims. [read post]
23 May 2011, 1:54 pm
Bayer AG, et al., Case No. 10-762, which involved manufacturers of Ciprofloxacin HCl (CIPRO) and whether a particular patent settlement agreement was per se lawful under the Sherman Act. [read post]
3 Apr 2012, 4:38 am
", here, this being a post on Case C 190/10 Génesis Seguros Generales Sociedad Anónima de Seguros y Reaseguros (Génesis) v Boys Toys Sa, Administración Del Estado, in which the Court of Justice had to sort out a lovely problem involving two trade mark applications filed on the same day [read post]
29 Aug 2012, 10:09 pm
Another patent settlement case that has been brewing for a while is in California State Court and involves patent settlement agreements between Bayer AG and several generic drug manufacturers with respect to generic versions of Bayer’s antibiotic drug CIPRO (ciprofloxacin HCl). [read post]
7 Oct 2021, 1:59 am
CFDT (currently Advens-Géocoton) continued to manage research, exporting and finance. [read post]
7 Oct 2019, 11:12 am
IP Enforcement GuestKat Peter Ling, in‘There is No Such Thing as a Free Launch – CJEU Does Not Follow AG on Compensation for Wrongful PI' , reports and critically comments on the latest ruling in Bayer Pharma case C-688/17. [read post]
12 Feb 2017, 7:46 am
--Notes and Questions G. [read post]
22 Oct 2015, 8:42 am
This one was filed by PhRMA, and this one was filed by something called the Medical Information Working Group, which is a consortium consisting of Amgen, Bayer, Boehringer, Lilly, Genentech, GSK, J&J, Novartis, Novo Nordisk, Pfizer, and Sanofi. [read post]
